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Cutaneous and renal glomerular vasculopathy
as a cause of acute kidney injury in dogs
in the UK
L. P. Holm, I. Hawkins, C. Robin, R. J. Newton, R. Jepson, G. Stanzani, L. A. McMahon,
P. Pesavento, T. Carr, T. Cogan, C. G. Couto, R. Cianciolo, D. J. Walker
To describe the signalment, clinicopathological findings and outcome in dogs presenting with
acute kidney injury (AKI) and skin lesions between November 2012 and March 2014, in whom
cutaneous and renal glomerular vasculopathy (CRGV) was suspected and renal thrombotic
microangiopathy (TMA) was histopathologically confirmed. The medical records of dogs with
skin lesions and AKI, with histopathologically confirmed renal TMA, were retrospectively
reviewed. Thirty dogs from across the UK were identified with clinicopathological findings
compatible with CRGV. These findings included the following: skin lesions, predominantly
affecting the distal extremities; AKI; and variably, anaemia, thrombocytopaenia and
hyperbilirubinaemia. Known causes of AKI were excluded. The major renal histopathogical
finding was TMA. All thirty dogs died or were euthanised. Shiga toxin was not identified in the
kidneys of affected dogs. Escherichia coli genes encoding shiga toxin were not identified in
faeces from affected dogs. CRGV has previously been reported in greyhounds in the USA,
a greyhound in the UK, without renal involvement, and a Great Dane in Germany. This is the
first report of a series of non-greyhound dogs with CRGV and AKI in the UK. CRGV is a disease of
unknown aetiology carrying a poor prognosis when azotaemia develops.
Introduction
Cutaneous and renal glomerular vasculopathy (CRGV) is a
disease of unknown aetiology, reported to cause ulceration of the
distal extremities in dogs. It is variably associated with clinically
relevant acute kidney injury (AKI). CRGV has been reported in
greyhounds in the USA (Carpenter and others 1988), a Great
Dane in Germany (Rotermund and others 2002) and a grey-
hound in the UK (Hendricks 2000).
The major renal histopathological lesion reported in CRGV is
thrombotic microangiopathy (TMA). Thrombotic microangiopa-
thies are characterised by inflammation and damage to vascular
endothelium, leading to widespread formation of microthrombi
and resultant consumptive thrombocytopaenia, microangio-
pathic haemolytic anaemia and multiorgan dysfunction (Noris
and others 2012). CRGV is the only canine disease previously
reported to cause vasculopathy preferentially affecting the small
vessels of the kidney and skin.
AKI can result from pre-renal (Waikar and others 2008), renal
(Rentko and others 1992, Vaden and others 1997, Eubig and
others 2005) and post-renal events (Fischer and others 2009).
Skin lesions are not commonly associated with AKI in dogs,
unless the AKI has resulted from immune-mediated disease
(Fournel and others 1992), certain neoplasms (Moore and others
1994), infectious diseases (Ferrer and others 1988) or vascular
events, such as vasculopathy (Goldfarb and Adler 2001).
The purpose of this report is to summarise the signalment,
clinicopathological findings and outcome in 30 dogs presenting
between November 2012 and March 2014, in which CRGV was
suspected clinically and TMAwas identified histopathologically.
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Materials and methods
Cases were identified by comprehensive search of computerised
record systems (using keywords) at two referral practices. Case
records were searched for the diagnosis of AKI, with subsequent
review of clinical case files and renal/dermal histopathology in
order to identify cases compatible with CRGV. Further case sub-
missions came from two other referral practices and 49 first
opinion practices. Practices became aware of CRGV through a
combination of: a letter in the veterinary literature (Walker and
McMahon 2013), media reports and information on a specialist
practice website. Records from suspected cases were thus
selected by the additional 51 practices both prospectively and
retrospectively (from memory rather than via computerised
record system searches) and were subsequently reviewed by two
of the authors (LPH, DJW). Dogs were included if they presented
between November 1, 2012 and March 31, 2014 with skin
lesions and AKI with no known identifiable cause, and with
renal histopathological evidence of TMA. Animals were defined
as having AKI if they had historical and laboratory evidence of
kidney injury with or without clinical oligoanuria (International
Renal Interest Society; www.iris-kidney.com, 2013).
Clinicopathological data are reported as median and range.
Histopathology
Representative sections from skin, kidney and other organs,
where possible, were paraffin embedded. Sections of 3–4 μm
were prepared from each of the tissues via microtome and
affixed to lysine-charged glass slides. These were stained by
standard technique with haematoxylin and eosin. In addition,
sections of the kidney were also stained with Warthin-Starry
silver stain and Periodic Acid Schiff. Kidneys from three dogs
were also stained with Masson’s trichrome and Jones
Methenamine silver method.
All of the renal histopathology was reviewed by a single vet-
erinary pathologist (IH). Renal samples from three dogs were
also submitted to a second veterinary pathologist (RC).
PCR for pathogenic Leptospira spp.i was carried out on sec-
tions of kidney and liver using an amplification mixture as previ-
ously described (Bourhy and others 2011). DNA was amplified
and detected on a Stratagene Mx3005P qPCR system, using a
program of 95°C for 10 minutes followed by 50 cycles of 95°C
for 30 seconds and 57°C for 60 seconds.
Fluorescence in situ hybridisation (FISH) for pathogenic bac-
teriai was performed on de-waxed tissue sections (kidney and
liver) using fluorescently labelled probes. Eubacteria were
detected using a mixture of three probes: GCTGCCTCCCG
TAGGAGT, GCAGCCACCCGTAGGTGT and GCTGCCACCCG
TAGGTGT. Leptospira were detected using probe CGGGTGCT
CCCCACTCAG. Escherichia coli were detected using probe
GCAAAGGTATTAACTTTACTCCC.
Viral metagenomicsii was performed on fresh kidney tissue,
liver and lymph node by random nucleic acid amplification after
enrichment for viral particles, followed by DNA sequencing and
similarity searches (Illumina MiSeq library) for sequences related
to those of known viruses (Victoria and others 2009).
PCR for Dog Circovirus was performed on splenic tissueii (par-
affin embedded samples and fresh frozen tissue) as previously
described (Li and others 2013).
FISH for Dog Circovirusi was performed on kidney tissue
using probe CTCAGACAGAGACACCGTTGCTATG as previ-
ously described (Li and others 2013). Identification of bacteria
was made against both unstained and organism-negative
controls.
FISH for Shiga toxin:i mouse anti-Shiga toxin antibody
(diluted 1/100) was incubated overnight at 4°C on renal tissue
sections, which were then washed three times and incubated
with goat anti-mouse G1 FITC-conjugated secondary antibody.
Slides were viewed using a fluorescence microscope.
PCR for Shiga toxin on renal tissue:iii DNA was extracted
from paraffin-embedded samples using the QIAamp®DNA FFPE
Tissue Kit (Qiagen, Hilden, Germany). PCR for verotoxin 1 and
2 was then performed as previously described (Burnens and
others 1995).
PCR for E. coli virulence genes on faeces:iv DNA was
extracted from colonies of E. coli cultured from faeces (Wizard
Miniprep DNA purification System, Promega). Multiplex PCRs
for eaeA, stx 1 and 2, LT1 and ST1 and 2 genes were performed,
as previously described (Pass and others 2000).
Results
Seventy-one cases of AKI with skin lesions were identified
within the defined time period for which there was clinical sus-
picion of CRGV. Of these, 41 cases were excluded due to limited
investigation and/or incomplete medical records. Thirty cases
met the inclusion criteria as affected cases with confirmed TMA
on renal histopathology.
Signalment, history and clinical signs
Breeds represented were English springer spaniel (n=5), cross-
breed above 20 kg (n=4), flat coated retriever (n=4), whippet
(n=3), border collie (n=2), Jack Russell terrier (n=2), Doberman
(n=2) and one each of, Labrador retriever, cocker spaniel,
Staffordshire bull terrier, Hungarian vizsla, Weimaraner,
Dalmatian, Tibetan terrier and crossbreed below 20 kg. Median
age was 4.90 years (1.00–11.75 years). Ten were male neutered,
seven were female neutered, six were male entire and seven were
female entire. Median weight was 23.2 kg (7.3–40.4 kg, n=28).
Affected cases were identified from multiple areas of north-
ern and southern England (Fig 1). Ten dogs had been in the New
Forest National Park shortly (four hours to 14 days) before devel-
oping skin lesions and/or becoming unwell.
Over the first 12 months of the study period (November 1,
2012–October 31, 2013), confirmed cases presented in November
(n=2), December (n=2), February (n=4), March (n=1) and May
(n=1). The remaining 20 confirmed cases presented between
November 1, 2013 and March 31, 2014.
Twenty dogs were vaccinated within the past year (vaccines
used included distemper, D; hepatitis, H; leptospirosis, L; parvo-
virus, P; and parainfluenza, Pi: DHLPPi n=10; DHPPi n=1; LP
n=1; DHLP n=2; L n=3; LPi n=2; type not recorded n=1), eight
were unvaccinated and vaccinal status was unknown in two dogs.
Skin lesions commonly appeared before signs of systemic
illness (lethargy, malaise, anorexia, vomiting, pyrexia; n=19).
Median time from development of skin lesions to diagnosis of
AKI was four days (1–9 days). Nine dogs had systemic signs con-
current with skin lesions and two dogs were systemically ill
before developing skin lesions. The management of skin lesions
before the development of AKI was variable: no medication
(n=7), NSAIDs alone (n=3), antibiotic alone (amoxicillin-
clavulanate n=4; marbofloxacin n=1) or a combination of
NSAIDs or dexamethasone, and antibiotic (n=12). Information
regarding previous medications was unavailable for three cases.
With the exception of NSAIDs, none of the dogs had known
access to nephrotoxins before initial presentation.
Distribution of skin lesions was: distal limbs (n=28),
ventrum (n=9) and oral cavity/muzzle (n=10). Sixteen dogs had
more than one lesion. Fourteen had lesions in multiple locations.
The appearance of the skin lesions was highly variable, ranging
from superficial erosion through to full thickness ulceration,
iUniversity of Bristol Veterinary Diagnostics, School of Veterinary
Sciences, University of Bristol, Langford, Bristol BS40 5DU, UK.
iiPesavento Research Group, University of California, Davis, School of
Veterinary Medicine, 1 Shields Avenue, Davis, CA 95616, USA.
iiiCenter for Zoonotic Diseases, Bacterial Diseases, and Antimicrobial
Resistance, Institute for Veterinary Bacteriology, University of Bern,
Hochschulstrasse 4, Bern CH-3012, Switzerland.
ivBatt Lab, University of Warwick Science Park, The Venture Centre, Sir
William Lyons Road, Coventry CV4 7EZ, UK.
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with erythema, oedema and exudation (Fig 2). Early lesions were
often erythematous and focal; they occasionally appeared vesicu-
lar, with ulceration and necrosis developing subsequently. The
skin lesions were often attributed to wounds, bites, stings or
focal dermatitis. Lesion size ranged from 0.5 to 5 cm in diameter.
Six dogs developed new limb and/or oral lesions while hospita-
lised. Lesions were typically painful on palpation and digital
lesions often caused lameness. Oral lesions were variable but
were most often focal erosions or ulcers (Fig 3).
The dogs’ clinical signs are summarised in Table 1. Pyrexia
generally occurred early in the course of illness (39.8°C;
39.4–40.1°C) and hypothermia typically developed later in the
disease course (37.4°C; 36.0–37.7°C).
Fourteen dogs lived in the same household as one of the 30
confirmed CRGV cases. Of these 14 dogs, two developed skin
lesions and AKI and six developed skin lesions without AKI
(n=8). Thirteen of these 14 dogs were not part of the study
population and the information on these dogs was obtained by
questioning owners. The eight dogs became unwell between 20
days before and six days after the confirmed CRGV case that
they lived with. All eight dogs were related to a confirmed
CRGV case and/or each other.
Clinicopathological findings
Selected haematology, serum biochemistry, urinalysis and sys-
tolic blood pressure measurement results for the 30 dogs are pre-
sented in Table 2, with further detail of clinicopathological
abnormalities presented in Table 3. Seven dogs demonstrated
normocytic, normochromic anaemia at presentation, with a
further eight dogs becoming anaemic after presentation.
Absolute reticulocyte count was only available for two dogs
which were anaemic at presentation and one dog subsequently.
The anaemia was pre- or non-regenerative (median reticulocyte
count 22.58×109/l). Blood smear examination was performed in
13 dogs and revealed schistocytes, burr cells and/or acanthocytes
in five dogs and was unremarkable in the remainder. Fifteen dogs
were thrombocytopaenic at presentation and four became
thrombocytopaenic.
N
S
EW Kilometers0 45 90 180
Location with single case
Location with 2 cases
Key
FIG 1: Map to show distribution of where confirmed cases lived. (Zoomed in view shows distribution of cases in the South of England as
there were proportionally more cases from this area)
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At presentation, 26 dogs were azotaemic. The non-azotaemic
dogs became azotaemic after initial presentation (less than
24 hours to six days later). Basal cortisol was measured in eight
dogs and excluded glucocorticoid deficient hypoadrenocorticism in
all. Clotting times, measured in eight dogs, were not consistent
with disseminated intravascular coagulation (DIC). Six dogs had
canine-specific pancreatic lipase immunoreactivity measured (Idexx
snap test n=4; quantitative cPLi n=2) and all had abnormal results
(680 and above 1000 mg/l—reference range less than 200 mg/l).v
Urine dipstick and sediment examination was performed in 17
dogs revealing: haemoglobinuria or myoglobinuria (n=16), pro-
teinuria (n=11, see Table 2) and glucosuria (n=6). Sediment
(a)
(b)
(c)
(d)
FIG 2: All images are photographs of lesions affecting confirmed
cases. (a) Superficial ulcer affecting medial thigh. (b) Deep
ulceration, erythema and exudation on a digit. (c) Erosion to carpal
pad, before cleaning. (d) The same lesion after clipping and cleaning
(a)
(b)
FIG 3: (a) Tongue lesions. (b) Tongue ulcer
vDogs were seen at numerous different veterinary practices using multiple
laboratories. Biochemistry reference ranges were therefore variable.
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examination revealed casts in nine dogs: granular (n=5), fatty
(n=1), hyaline (n=2) and not described (n=1). Urine culture was
negative in 11 of 12 dogs (faecal contaminants were cultured from
the remaining case). Urine toxicology was negative in five of six
dogs tested (Carmichael Torrance Veterinary Diagnostic
Laboratory). Pentaethylene glycol (trace) was detected in one dog.
At presentation, nine dogs were oliguric, two were anuric
and seven had normal urine output. Urine output was unknown
in 13 dogs. International Renal Interest Society (IRIS) AKI
grading at presentation was: grade I (n=3), II (n=4), III (n=8),
IV (n=14) and V (n=1) (www.iris-kidney.com, 2013).
Abdominal ultrasonography (performed by a European
diploma holder in Diagnostic Imaging in 11 dogs and a general
practice veterinary surgeon in 2 dogs) revealed no evidence for
chronic kidney disease (CKD) or pyelectasia (n=13). The
kidneys appeared unremarkable in eight dogs and the remaining
five had bilateral hyperechoic renal cortices. Three dogs had pos-
sible evidence for gastritis (thickened hypoechoic gastric rugal
folds n=1; thickened hyperechoic rugal folds n=1; reduced
gastric wall layer definition n=1); one dog had hyperechoic
small intestinal mucosal striations and thickening and uneven-
ness of the colonic mucosa which may have suggested entero-
colitis. One additional dog had evidence for hepatopathy
(hypoechoic hepatic parenchyma with cuffing of the portal
veins). No other relevant abnormalities were identified on
abdominal ultrasonography.
Leptospirosis microscopic agglutination testing (MAT) was
performed in 15 cases. Ten had negative titres, obtained a
median of three days (1–8 days) after the development of sys-
temic signs. Five dogs had positive titres; their results and the
results of additional leptospirosis testing are summarised in
Table 4. FISH for Leptospires was performed on renal tissue from
seven dogs and liver tissue from one dog.vi A positive result was
obtained from six renal samples; Leptospires were seen in small
localised clusters in three dogs (one of whom had a negative
MAT titre) and diffusely throughout the renal tissue in three
dogs (one of whom was not tested for Leptospirosis by MAT).
The remaining results were negative. Leptospirosis PCR was per-
formed on the renal tissue of three of the dogs with positive
FISH results; one dog had a negative result and one had a posi-
tive result; one dog had PCR performed at two laboratoriesvi vii
and discordant results were obtained. Leptospirosis PCR was per-
formed on liver tissue from one dogvi and the result was
negative.
Four dogs were tested for Dog Circovirus via PCR on splenic
tissue, three via PCR on peripheral EDTA blood and six via FISH
on renal tissue and all results were negative. Viral metagenomics
was performed on renal tissue from two dogs; and on liver,
spleen and lymph node from one of those dogs. No match was
identified between viral nucleic acids enriched from those
samples to known viruses.
Borrelia PCR (n=5) and Borrelia serology (n=2) results were
negative. Renal heavy metal concentrations (lead, arsenic and
cadmium) were measured in two dogs (Animal Health and
Veterinary Laboratories Agency, Winchester) and were below
reported reference intervals in both. Routine aerobic and anaer-
obic bacterial culture was performed on renal tissue from three
dogs and results were negative.
Faecal culture, performed in seven dogs, yielded E. coli. PCRs
for E. coli virulence genes (eaeA, stx 1 and 2, LT1 and ST1 and 2)
were negative in all seven, providing no evidence for infection
with enteropathogenic E. coli, verotoxigenic E. coli or enterotoxi-
genic E. coli.
Skin lesion cultures, performed in 11 dogs, were positive in 7,
yielding Staphylococcus intermedius (n=1), Staphylococcus aureus
(n=1), coagulase positive Staphylococcus (n=1), non-haemolytic
Streptococcus (n=1), β haemolytic Streptococcus (n=1), Enterococcus
(n=1), E. coli (n=3), Pseudomonas aeruginosa and Corynebacterium
(n=1). Three dogs cultured more than one bacterium. Blood
culture was performed in one dog and was negative.
Histopathology
Full post mortem examination was performed in five dogs by
pathologists with a Diploma of the American or European
College of Veterinary Pathologists, or equivalent. Tissue samples
for histopathology were obtained post mortem by the case veter-
inarians in the remaining 25 cases. Renal histopathology was
available for all 30 dogs and skin histopathology for 24 dogs. The
most prominent histological changes were noted in the kidney
and skin. For the kidney, the most striking changes involved the
glomeruli, with frequent fibrinoid necrosis of glomerular arter-
ioles, characterised by distortion of vessel walls with an eosino-
philic, hyalinised, smudgy material, intermingled with low
numbers of degenerate and viable neutrophils, fragmented red
blood cells and mild amounts of karyorrhectic debris (Fig 4).
Frequent vessels were occluded by thrombi. The majority of the
glomeruli were affected and for individual glomeruli these
changes ranged from mild and segmental to global and severe.
Also, frequent glomerular tufts were congested and partially
occluded by haemorrhage. Increased cellularity of the glomerular
tufts consistent with endothelial cell hypertrophy and swelling
was identified in 17 cases. Fibrinoid necrosis of intralobular and
arcuate arteries was occasionally observed (Fig 4). Twenty-nine
dogs had concurrent evidence of tubular necrosis, ranging from
mild to marked, often with concurrent evidence of tubular resti-
tution. In affected kidneys, micro-organisms, viral cytopathic
effects and metazoan parasites were not identified. When per-
formed, Warthin-Starry stains did not reveal argyrophilic organ-
isms (Leptospires) within the tissue sections.
In the skin samples, the epidermis was focally to diffusely
ulcerated. The subjacent dermis was often undergoing coagula-
tive necrosis. At the level of the adnexa, the hair follicles had
reduced to absent sebaceous glands, reduced cellularity and were
separated by increased fibrous tissue and an attenuated follicular
epithelium. The affected follicles were often bordered by variable
numbers of neutrophils, foamy macrophages and karyorrhectic
debris (Fig 5); this often obscured the follicular epithelium inter-
face and sebaceous gland units. In most cases, the deep dermis
and subcutis were thickened by a layer of maturing fibrovascular
tissue. Occasionally this fibrovascular tissue replaced portions of
the adnexa. In a few cases (n=6), fibrinoid necrosis was observed
in the small dermal arterioles (Fig 6). Rarely, thrombi were iden-
tified in such vessels. In one case, similar necro-ulcerative
changes were identified in skin from the lip. In samples from the
oral cavity lesions, similar ulceration of the mucosa was observed
TABLE 1: Summary of presenting clinical signs of the 30
affected dogs
Clinical sign Number of dogs affected
Skin lesions 30
Anorexia 20
Vomiting 20
Lethargy 19
Hypothermia 19
Lameness 10
Icterus 6
Pyrexia 6
Diarrhoea 4
Petechiae 4
Seizures 3
Haematochezia 2
Haematemesis 1
Epistaxis 1
Polyuria/polydipsia 1
Ataxia 1
Behaviour change 1
viUniversity of Bristol Veterinary Diagnostics.
viiIdexx Laboratories.
April 11, 2015 | Veterinary Record
Paper
group.bmj.com on July 25, 2017 - Published by http://veterinaryrecord.bmj.com/Downloaded from 
with associated necrosis, inflammation and fibrovascular change
of the submucosa.
The majority of other tissues evaluated (stomach, n=2;
small intestine, n=6; colon, n=2; liver, n=14; pancreas, n=4;
heart, n=2; spleen, n=9; lung, n=1; brain, n=1; eye, n=1; saliv-
ary gland, n=1; urinary bladder, n=3; tongue, n=2; soft palate,
n=1; bone marrow, n=2; adrenal gland, n=2; tonsil, n=1; skel-
etal muscle, n=1 and lymph node, n=2) appeared unremarkable,
but occasionally exhibited mild, non-specific changes (see online
supplementary appendix 1).
Electron microscopy was performed in three dogs and
revealed distension of the glomerular capillary loops by erythro-
cytes, occasional schistocytes and rare polymorphonuclear cells.
Endothelial cells, when identifiable, were severely swollen.
Podocyte foot processes were globally effaced. Occasionally,
mesangiolysis (dissolution of mesangium) was noted. Immune
complexes were not identified. Immunostaining was negative for
IgG, IgM, IgA, C3, C1q, kappa light chain (KLC) and lambda
light chain (LLC) (Fig 7).
Renal tissue from two dogs was submitted to two separate
laboratories with both laboratories receiving both samples
(Department of Medical Microbiology and Immunology, School
of Medicine, University of California, Davis, USA; University of
Bristol Veterinary Diagnostics, School of Veterinary Sciences,
University of Bristol, Langford, Bristol, UK) for evaluation with
a broad spectrum set of 16S rRNA-directed probes (to detect bac-
terial genetic material). From one laboratory, a clear 16S band
was identified in the tissue of one dog and a faint band in the
other. Staphylococcaceae were identified in both samples. The
other laboratory identified solely Leptospires in both samples.
PCR for verotoxin 1 and 2, performed on the kidneys from
four dogs, gave negative results. FISH for shiga toxin, performed
on the kidneys from six dogs, was also negative.
Management
Ten cases were managed at referral centres and 20 in primary
practice. Initial management typically consisted of intravenous
fluid therapy (n=26) and antibiotic therapy (n=26) and is sum-
marised in Table 5. Ten cases were managed with an indwelling
urinary catheter for measurement of urine output. Three cases
underwent continuous renal replacement therapy.
Outcome
Twenty-four dogs died, or were euthanised, solely due to their
disease and six were euthanised at the owners’ request. IRIS AKI
grade progressed in 10 dogs, reduced in 2 and was unchanged in
12. Terminally, IRIS grades were: II (n=1), III (n=8), IV (n=13),
V (n=3) and unknown (n=5). Causes of death/euthanasia were:
oligoanuria (n=9), anaemia and thrombocytopaenia (n=2), pro-
gressive azotaemia (n=6), unspecified clinical deterioration
(n=3), suspected DIC (n=1), dyspnoea (n=1), collapse (n=1),
ascites (n=1) and owners’ request due to concurrent disease(s),
financial constraints or concern regarding prognosis (n=6).
TABLE 3: Frequency of clinicopathological abnormalities
Results at presentation
Results for additional patients identified as
developing the abnormality during
hospitalisation
Abnormality Number of patients Median Range Number of patients Median Range Reference interval
Anaemia 7/28 30.2 24.0–33.2 8 31.1 7.7–35.1 37–55%
Thrombocytopaenia 15/26 46 1–81 4 49 9–162 175–500×109/l
Elevated serum urea concentration 28/30 46.4 12.1–85.1 2 37.7 25.4–50.0 2.0–9.0 mmol/l
Elevated serum creatinine concentration 26/30 476 155–900 4 494.5 352–671 (40–106 mmol/l 13 dogs;
44–159 mmol/l, 16 dogs)
Hyperbilirubinaemia 9/27 27 16–338 4 55 21–640 0–15 mmol/l
Hypoalbuminaemia 10/27 23.5 14–25 9 24 17–25 26–40 g/l
Hypertension 8/11 181 102–280 1 162 162 100–150 mmHg
TABLE 2: Selected data for the 30 confirmed cases
At presentation Last available result
Parameter Median Range Median Range Reference interval
Haematocrit (%) 43.9 (n=28) 26.0–65.3 34.3 (n=23) 7.7–55.8 37–55%
Platelet count (×109/l) 78 (n=26) 1–401 50 (n=20) 9–411 175–500×109/l
Neutrophil count (×109/l) 11.6 (n=27) 5.19–37.90 10.8 (n=20) 4.49–33.9 2.8–10.5×109/l
Urea (mmol/l) 46.4 (n=30) 3.6–85.1 48.19 (n=25) 17.3–113.8 2.0–9.0 mmol/l
Creatinine (mmol/l) 406.5 (n=30) 71–900 527.0 (n=25) 209.0–1171.0 40–106 mmol/l (13 dogs)
44–159 mmol/l (16 dogs)
Phosphate (mmol/l) 3.12 (n=26) 1.28–6.20 3.54 (n=19) 2.01–5.50 0.8–1.6 mmol/l (14 dogs)
0.81–2.20 mmol/l (12 dogs)
ALT (U/L) 119 (n=25) 48–950 92 (n=21) 39–1260 0–25 U/L (10 dogs)
10–100 U/L (15 dogs)
ALKP (U/L) 91.5 (n=28) 16–650 63 (n=23) 16–1395 0–50 U/L (11 dogs)
23–212 U/L (17 dogs)
Total bilirubin (mmol/l) 12.0 (n=27) 0–338 11.3 (n=18) 5.0–640.0 0–15 mmol/l
AST (U/L) 76.5 (n=6) 51–473 112 (n=5) 57–1179 0–49 U/L
CK (U/L) 206 (n=8) 112–881 235 (n=7) 106–963 0–190 U/L
Albumin (g/l) 27 (n=27) 14–36 23 (n=23) 14–34 26–40 g/l
Globulin (g/l) 33 (n=25) 22–58 25 (n=15) 18–47 20–47 g/l
Sodium (mmol/l) 144 (n=18) 139–152 147 (n=15) 136–157 139–154 mmol/l
Potassium (mmol/l) 4.2 (n=18) 2.8–5.3 4.5 (n=15) 2.6–6.7 3.5–5.8 mmol/l
Prothrombin time (seconds) 14 (n=8) 4–19 No further results available 12–17 seconds
Activated partial thromboplastin time (seconds) 96.5 (n=8) 12–143 No further results available 71–102 seconds
Urine specific gravity 1.020 (n=16) 1.005–>1.050 No further results available
Urine protein: creatinine ratio 5.6 (n=11) 1.35–16.58 No further results available <0.5
Systolic blood pressure (mmHg) 176 (n=11) 102–280 174 (n=9) 110–290 100–150 mmHg
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Median time from onset of clinical signs to death or euthanasia
was seven days (1–16 days).
Discussion
CRGV has been recognised in the USA for almost 30 years
(Carpenter and others 1988), but has only sporadically been
reported in individual dogs elsewhere. This is the first case series
of dogs with CRGV in the UK.
Most of the dogs in this case series were initially evaluated at
their primary practice for a skin lesion (or lesions) which was
considered consistent with pyoderma, pododermatitis, a bite/
sting, or a wound. Systemic signs developed a median of four
days later, but some dogs were unwell concurrently. Initial inves-
tigations revealed renal azotaemia attributable to AKI. Pre-renal
causes were excluded via assessment of urine specific gravity,
lack of response to intravenous fluid therapy and exclusion of
hypoadrenocorticism. Abdominal imaging, where available, was
used to exclude post-renal causes. CKD was excluded via a com-
bination of clinical history and imaging findings. Eleven of the
dogs (36.7 per cent) received NSAIDs before the diagnosis of
AKI; although it is possible that their use exacerbated AKI, the
histopathologic lesions were not consistent with NSAIDs being
the sole cause of the AKI.
Other known causes of AKI were explored as thoroughly as
possible in most of the dogs. Leptospirosis, which can cause
similar clinical and laboratory signs to those seen in this case
series (Rentko and others 1992, Birnbaum and others 1998,
Greene and others 2006, Sykes and others 2011), was further
investigated with serology, PCR on peripheral blood, renal and
hepatic tissue, and FISH on renal and hepatic tissue. The five
dogs with positive Leptospirosis titres (1:100–1:800) had been
vaccinated less than 1 year before testing and although vaccinal
titres often decline by four months post-vaccination, they can
sometimes persist for longer (Sykes and others 2011) leading to
false-positive results. Additionally, only single titres above 1:1600
are considered significant for indicating infection in vaccinated
dogs (Tangeman and Littman 2013), whereas the positive titre
results obtained in the five dogs in this study were relatively low.
It is possible that the titres would have been higher if MAT
testing had not been performed so early in the disease process.
Only 55 per cent of dogs with leptospirosis were diagnosed by a
single MAT titre obtained within 72 hours of initial presentation
in one study (Tangeman and Littman 2013). Convalescent phase
samples could not, however, be obtained in the dogs in this
study given the short survival time.
In cases of acute leptospirosis, histopathology often reveals
mild renal tubular necrosis and interstitial oedema (Greene and
others 2006) with focal areas of hepatic necrosis characterised by
cellular disassociation of the hepatic cords (Van den Ingh and
others 2006). This contrasts with the histopathological findings
in this case series; no typical hepatic lesions were identified and
the predominant renal lesion was TMA. Acute to peracute, peri-
acinar hepatocellular loss with associated haemorrhage was
observed in one dog in this series. This raised concern for lepto-
spirosis, however, this case exhibited fibrinoid necrosis of small
portal vessels, and consequently the periacinar changes may also
have represented ischaemic change associated with the fibrinoid
necrosis. In addition, both PCR and FISH on paraffin embedded
sections of the affected liver were negative for Leptospira sp.,
making acute leptospirosis less likely. There was no evidence of
argyrophilic Leptospires with silver staining, although this tech-
nique can fail to identify Leptospires during acute leptospirosis
(Greene and others 2006). With the exception of calcinosis cutis,
which was not identified in any dog in this series, skin lesions
have not previously been reported in association with canine
leptospirosis (Munday and others 2005).
FISH and PCR detected Leptospires in the renal tissues of
some of the CRGVaffected dogs reported in this series; however,
this does not confirm clinical infection, as some dogs are asymp-
tomatic maintenance hosts for Leptospires (Monahan and others
2009). Although a causal relationship between leptospirosis and
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CRGV cannot be fully excluded, the low number of positive
leptospirosis test results in this case series was felt unlikely to
support a diagnosis of acute leptospirosis as the clinical picture,
outcome and histopathological findings differed significantly
from those previously reported with acute leptospirosis.
Histopathologically, AKI in the dogs in this case series was
found to be attributable to TMA. A search of the International
Veterinary Renal Pathology Service database of more than 1000
renal biopsies from small animals, revealed TMA to account for
below 1 per cent of all diagnoses reached (Cianciolo R, unpub-
lished data). TMAs are characterised by inflammation and damage
to vascular endothelium, leading to widespread formation of
microthrombi, consumptive thrombocytopaenia, microangio-
pathic haemolytic anaemia and multiorgan dysfunction (Noris
and others 2012). Five cases in this series (38.5 per cent of dogs in
whom a blood smear was examined) had evidence for burr cells,
schistocytes or acanthocytes; additionally 19 dogs were thrombo-
cytopaenic and 13 dogs were hyperbilirubinaemic by the time of
death. All of these findings can be the result of microangiopathy
(Rebar and others 1981, Ruggenenti and others 2001); however,
other mechanisms could also have been contributing to the
anaemia, thrombocytopaenia and hyperbilirubinaemia.
Known differential diagnoses for canine TMA include CRGV
(Carpenter and others 1988) and haemolytic uraemic syndrome
(HUS). HUS has previously been reported in five dogs (Holloway
and others 1993, Chantrey and others 2002, Dell’Orco and
others 2005), three cats (Aronson and Gregory 1999) and a
number of other species (Morris and others 1987, Roby and
others 1987, Garcia and others 2002, Dickinson and others
2008). CRGV has been almost exclusively reported in grey-
hounds (Carpenter and others 1988, Hendricks 2000), although
there is one report of an affected Great Dane (Rotermund and
others 2002). In contrast, HUS in dogs has been reported in a
variety of breeds: Yorkshire terrier, miniature poodle, Labrador
retriever, German shepherd dog and boxer (Holloway and others
1993, Chantrey and others 2002, Dell’Orco and others 2005).
Similarly, many breeds were represented in this case series. It is
unclear at this time whether canine HUS and CRGV are truly
two distinct disease processes. Dogs with CRGV typically
present with acute onset skin lesions affecting the distal limbs;
kidney injury and haematological abnormalities are variably
reported (Carpenter and others 1988). In contrast skin lesions
have not previously been reported in dogs with HUS (Holloway
and others 1993, Chantrey and others 2002, Dell’Orco and
others 2005). The proportion of dogs in the UK that develop
CRGV without developing AKI is unknown at this stage;
however, 42.9 per cent of dogs in contact with those reported in
this study, developed skin lesions without biochemical evidence
of AKI and it would have been interesting to review dermal and
renal histopathology in these dogs had it been available. Previous
reports indicate that non-azotaemic dogs with CRGV tend to
have reduced glomerular filtration rates and renal histopathology
showing mild, multifocal, endothelial glomerular changes
(Hertzke and others 1995, Cowan and others 1997).
Clinicopathologic findings previously reported in dogs with
CRGV include anaemia, thrombocytopaenia, azotaemia, high
serum liver enzyme activity, high muscle enzyme activity,
haematuria, proteinuria and poorly concentrated urine
(Carpenter and others 1988, Cowan and others 1997), similar to
the abnormalities identified in the dogs in this case series.
Previous reports have not further classified the anaemia
(Carpenter and others 1988, Cowan and others 1997). In this
case series the anaemia appeared pre- or non-regenerative and
the former was considered most likely. Possible aetiologies con-
sidered included gastrointestinal haemorrhage secondary to
uraemia or microangiopathic red cell injury. Hypoalbuminaemia
(identified in 63.3 per cent of the confirmed cases in this series)
may support gastrointestinal haemorrhage, without excluding
other possible causes.
Histopathological findings previously reported with CRGV
(Carpenter and others 1988, Hertzke and others 1995) correlate
with those seen in this case series. The majority of the skin
(a) (b)
(c) (d)
FIG 4: Photomicrographs of a glomerulus and an intralobular artery from a dog with CRGV, stained with haematoxylin and eosin [H&E] (a and
c) and Masson’s trichrome (b and d). There is fibrinoid vascular necrosis (asterisks) of intralobular arteries and arterioles. Glomerular
capillaries are severely distended and contain red blood cells, many of which are fragmented. Distension of glomerular capillaries is due to
dissolution of the mesangial matrix (mesangiolysis). Tubules are undergoing degeneration and necrosis; most tubules contain protein casts
whereas some contain red blood cell casts.
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lesions in this case series, as in previous reports of CRGV,
involved the distal extremities. This could be attributable to the
increased number of smaller calibre vessels in this location and
an increased propensity to infarction.
Microscopic lesions in abdominal organs other than the
kidneys in dogs with CRGV were reported as being consistent
with uraemia and hypovolaemia in one report (Carpenter and
others 1988). Hyalinisation and rare thrombi were identified in
the submucosa of the stomach, and small and large intestine in
another report (Hertzke and others 1995). Fibrinoid necrosis of
smaller vessels was identified in this case series but thrombi
were not identified in abdominal organs other than the kidney.
Glomerular ultrastructural changes previously reported with
CRGV (Hertzke and others 1995) were similar to the changes
identified in this case series. Immune complexes, complement
and immunoglobulins have not previously been identified in the
kidneys of dogs affected by CRGV (Carpenter and others 1988,
Hertzke and others 1995) and were not identified in this popula-
tion of UK dogs.
FIG 5: Photomicrograph of a necrotic hair follicle with neutrophilic
infiltrates
FIG 6: Photomicrograph of a small dermal artery with fibrinoid
necrosis of the vessel wall
FIG 7: Electron micrograph of a glomerular capillary loop from a dog
with cutaneous and renal glomerular vasculopathy (CRGV). There
are multiple deformed red blood cells (white asterisks) and swollen
endothelial cells (black asterisks). A few small aggregates of fibrin
tactoids are present at the periphery of the capillary loop (arrows)
TABLE 5: Summary of case management
Treatment Number of cases
Antibiotics
Amoxicillin-clavulanate 21
Marbofloxacin 4
Enrofloxacin 4
Cefalexin 2
Clindamycin 1
Metronidazole 1
Pradofloxacin 1
Cefuroxime 1
>1 antibiotic 5
No antibiotic 3
Not recorded 1
Route of antibiotic administration
Intravenous 15
Oral 3
Subcutaneous 8
Other medications
Corticosteroids (anti-inflammatory dose) 7
Corticosteroids (immunosuppressive dose) 1
Amlodipine 2
Furosemide 16
Mannitol 6
Dopamine 1
Pentoxyfilline 1
Blood products
Whole blood 1
Packed red cells 1
Fresh frozen plasma 1
CRRT 3
CRRT, continuous renal replacement therapy
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As discussed, canine TMAs can be the result of CRGVor HUS,
which may represent two variants of the same disease with the
same aetiology, or which may be two separate diseases. The most
common form of HUS in human beings, termed STEC-HUS or D
+HUS, is associated with E. coli or Shigella dysenteriae shiga toxin
(Uchida and others 1999, Noris and others 2012, Salvadori and
Bertoni 2013). Co-infection with Salmonella or Campylobacter may
also be important (Ardissino and others 2014a). STEC-HUS typic-
ally starts with watery, then haemorrhagic, diarrhoea followed by
thrombocytopaenia, haemolysis and azotaemia (Tarr and others
2005, Salvadori and Bertoni 2013). STEC-HUS appears a median
of seven days after the onset of diarrhoea (Tarr and others 2005).
In this case series, a diarrhoeic prodrome was only reported in four
dogs; however, if owners were not specifically questioned about
prodromal diarrhoea, this information may have been missed. In
contrast, four of the five dogs previously reported with HUS had
diarrhoeic prodromes (Holloway and others 1993, Dell’Orco and
others 2005).
E. coli shiga toxin has not been identified in dogs with HUS
(Holloway and others 1993, Chantrey and others 2002,
Dell’Orco and others 2005) or CRGV (Rotermund and others
2002). Shiga toxin has been identified in one horse (Dickinson
and others 2008) and two of three rabbits previously reported
with HUS (Garcia and others 2002). Shiga toxin producing
E. coli, Salmonella and Campylobacter were not identified in the
faeces or kidneys of dogs in this study. Reasons for failing to
identify toxin, or causative bacteria, may have included previous
antibiotic administration, inappropriate sample handling or late
collection of samples. In human beings, recovery of toxin-
producing E. coli is highly dependent upon faecal culture being
performed within six days of the onset of diarrhoea (Tarr and
others 1990).
In one case series of 18 dogs with CRGV in the USA, season-
ality was reported as early winter and early summer (Cowan and
others 1997); in this case series, dogs presented over winter and
early spring. In contrast, STEC-HUS in people is more com-
monly reported in the summer (Milford and others 1990, Boyce
and others 1995). Seasonality of canine HUS has not been
reported (Holloway and others 1993). Any potential seasonal dis-
tribution of CRGV may become apparent with time, provided
disease surveillance continues.
Human STEC-HUS tends to occur either sporadically or in
small geographical clusters (Milford and others 1990, Tarr and
others 2005, Salvadori and Bertoni 2013), which may be similar
to the findings in this case series and epidemiological investiga-
tions are ongoing. Although cases were reported from across the
north and south of England, 36.7 per cent came from The New
Forest, Hampshire. This high percentage could, however, be
attributed to the geographical location of the primary investiga-
tors in Hampshire and increased awareness amongst local
veterinarians.
In people, genetic or acquired conditions causing comple-
ment dysregulation can cause another TMA, known as atypical
HUS (aHUS) (Noris and others 2012). Skin lesions have been
reported alongside haemolysis and AKI with aHUS (which is
not the case with STEC-HUS), but the incidence is rare
(Ardissino and others 2014b). Even in patients with multiple
genetic defects, aHUS may not develop until adulthood and an
environmental trigger is considered likely for the development of
disease (Salvadori and Bertoni 2013). Atypical HUS has not been
reported in dogs; however, CRGV may bear some resemblance to
this disease, especially given the concurrent findings of skin
lesions and AKI identified in both diseases. An infectious or
environmental trigger for CRGV may be suspected, given the
number of in-contact dogs in this case series that developed skin
lesions with or without AKI. It was also interesting to note that
all of the affected in-contact dogs were related either to each
other and/or to a confirmed case.
Dog Circovirus has recently been isolated from the tissues of
dogs with vascular and granulomatous disease of unknown
origin (Li and others 2013); however, a viral aetiology was
considered unlikely in this case series: PCR, FISH and viral meta-
genomics (performed in an effort to detect any encapsulated
virus potentially present in kidney tissue) results were negative,
and histopathologically there was no evidence of viral cytopathic
effect (cytoplasmic inclusion bodies) in any of the tissues exam-
ined. Negative results for viral metagenomics do not completely
exclude a viral aetiology, however. The results could indicate that
virus was present in low copy number, or that the virus was too
remotely related to known viruses used for sequence alignment,
or that the sample used was too autolysed to preserve the virus.
The significance of the Staphylococcaceae detected by 16S
rRNA-directed probe in two dogs in this case series is unclear
but, contamination with commensal skin bacteria is considered
more likely than disease-causing infection, as the kidneys were
not kept sterile before the DNA extraction phase. The negative
urine and renal tissue culture results obtained support this
hypothesis.
It is currently unknown if CRGV is a novel canine disease or
if it is a variant of HUS, aHUS or indeed one of the other TMA’s
reported in man. These include ‘HUS of unknown aetiology’
and thrombotic thrombocytopaenic purpura (TTP) (Noris and
others 2012). Evaluation of the canine complement system may
provide further information regarding the aetiology of CRGV.
Management of human TMA’s is dependent upon the under-
lying cause. Plasma therapy, antibiotic administration, monoclo-
nal shiga toxin antibodies and renal transplantation have all
been used in STEC-HUS. A recombinant, anti-C5 antibody (ecu-
lizumab) is the treatment of choice for human aHUS (Kavanagh
and others 2013, Salvadori and Bertoni 2013) but the cost has
prohibited its evaluation in dogs. Plasma exchange remains the
treatment of choice for human TTP (Blombery and Scully 2014)
and is a useful therapy for aHUS (Kavanagh and others 2013).
Monoclonal antibody therapy to CD20 and classical immuno-
suppressive drug therapy have also been reported for manage-
ment of human TTP (Blombery and Scully 2014). One dog with
CRGV was reportedly ineffectively managed with immunosup-
pressive therapy (Rotermund and others 2002). The efficacy of
plasma therapy and monoclonal antibody therapy has yet to be
evaluated in CRGV.
Case selection bias could have been introduced in this case
series. Fifty one of the 53 practices involved identified cases
based on their awareness of CRGV and the presenting signs.
Cases may have been missed in these practices without compre-
hensive searching of computerised record systems. The actual
number of dogs affected by CRGV may therefore be higher than
reported in this case series.
Six surviving dogs were strongly suspected, by the authors,
to be suffering from CRGV. Renal histopathology was not avail-
able to confirm the diagnosis as, invasive procedures, like renal
biopsy in patients with AKI showing apparent improvement to
symptomatic management, are considered clinically difficult to
justify. This may suggest that CRGV is not an invariably fatal
disease.
Conclusion
CRGV is a TMA of unknown aetiology which, when azotaemia
develops, currently appears to carry a grave prognosis.
Vasculopathy, preferentially affecting the small vessels of the
skin and kidneys in dogs, as identified in this case series, appears
to be unique to CRGV and has not, to the authors’ knowledge,
been reported associated with any other canine disease.
Although this case series provides useful initial information
about CRGV in the UK, the retrospective multicentre nature of
the study is a limitation. Continued detailed clinical, clinico-
pathological and epidemiological evaluation will further enhance
the understanding of the disease and will hopefully help to iden-
tify possible triggers, define prognostic indicators and determine
the most appropriate management for these patients. The ques-
tion remains as to whether this is an emerging disease or, one
that was previously present but unrecognised.
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